Question 45

Drug recalls are initiated due to mislabeling, contamination, and lack of potency.

Mislabeling, contamination, and lack of potency are serious issues in pharmaceuticals that can lead to drug recalls to ensure patient safety and product integrity.

A) Drug recalls

This option is correct because drug recalls are specifically implemented when a pharmaceutical product is found to have defects such as mislabeling, contamination, or insufficient potency, which can pose significant risks to consumers.

B) Stock rotation

Stock rotation refers to the practice of managing inventory to ensure that older products are used before newer ones, primarily to minimize waste. It does not directly address issues of mislabeling, contamination, or potency, making it an incorrect choice.

C) Environmental evaluations

Environmental evaluations typically involve assessing the impact of pharmaceutical manufacturing or disposal on the environment. While important, they do not relate to the safety and efficacy concerns that prompt drug recalls, rendering this option incorrect.

D) Pharmaceutical waste procedures

Pharmaceutical waste procedures focus on the safe disposal of unused or expired medications. Although they are crucial for public health and safety, they do not address the immediate concerns of mislabeling or contamination that would lead to recalls.

Conclusion

The initiation of drug recalls is a critical response to safety issues involving pharmaceuticals, specifically when there are risks associated with mislabeling, contamination, or lack of potency. Other options, such as stock rotation, environmental evaluations, and pharmaceutical waste procedures, do not address these urgent safety concerns, confirming that option A is the only appropriate answer.